Global Alopecia Market

Alopecia Comprehensive Study by Type (Oral treatment, Topical treatment, Other treatment), Application (Homecare Settings, Dermatology Clinics, Others (Salons)), Treatment (Vitamins and Supplements, Shampoos and Conditioners, Others (Serums, Gels, and Oils)), Gender (Male, Female) Players and Region - Global Market Outlook to 2028

Alopecia Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 6.92%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
According to the American Hair Loss Association, androgenetic alopecia accounts for over 95% of hair loss in men. Alopecia is a term that refers to excessive hair damage under certain medical conditions or dietary issues. Factors like sedentary lifestyle, and unhealthy diets are a leading to loss of hair among people. Further, ageing and hormonal imbalance, increasing chronic disease like arthritis, cancer, hypertension, depression also leads to hair loss are driving the Global Alopecia Market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledLifes2good (Ireland), Kirkland Signature (United States), Johnson & Johnson Services (United States), Dr. Reddy's Laboratories (India), Cipla Inc.(India), Alpecin (Germany), Vitabiotics Ltd. (United Kingdom), Sun Pharmaceuticals Industries Ltd. (India) and Phyto Ales Group (France)


According to AMA, the market for Alopecia is expected to register a CAGR of 6.92% during the forecast period to 2028. This growth is primarily driven by Increasing Level of Genetic Disorders, Air and Water Pollution, Rising Healthcare Expenditure, Effective Treatment Option for Hair Treatment & its Awareness and Demand for Alopecia Treatment in Developing Countries.

Globally, a noticeable market trend is evident Changing Lifestyle of People The Diseases & Therapeutic Areas sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Lifes2good (Ireland), Kirkland Signature (United States), Johnson & Johnson Services (United States), Dr. Reddy's Laboratories (India), Cipla Inc.(India), Alpecin (Germany), Vitabiotics Ltd. (United Kingdom), Sun Pharmaceuticals Industries Ltd. (India) and Phyto Ales Group (France), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The market is fragmented with numerous players who continuously involved in identifying Drugs and Treatment for Alopecia. The large populations suffering from Alopecia and the rising awareness levels pertaining to the available therapeutic options are driving the market. Further intensive research activities towards introducing innovative treatment options and growth in disposable incomes of the general population will allow significant growth of this market.

Key Developments in the Market:
November 2018, Sammued LLC Company announced the first subject dose in Phase 2/3 trial of SM04554, a topical small molecule Wnt pathway activator which specifically stimulates hair growth in men and women.
July 2018, The Bald Truth was launched which is a weekly online streamed radio show hosted by Spencer Kobren, founder and president of the American Hair Loss Association. and A radio program involved in spreading awareness about the different types of alopecia affecting people and about the varied products used for the effective treatment of alopecia that is currently available in the market.

Regulatory Insights:
July 2018, The Food and Drug Administration (FDA) approves of the Janus kinase inhibitors (JAK) drugs that stimulate the growth of hair follicles with minimal side effects.

Influencing Trend:
Changing Lifestyle of People and Growing Geriatric Population Undergoing Alopecia Treatment

Market Growth Drivers:
Increasing Level of Genetic Disorders, Air and Water Pollution, Rising Healthcare Expenditure, Effective Treatment Option for Hair Treatment & its Awareness and Demand for Alopecia Treatment in Developing Countries

Challenges:
Cost Factor Associated with the Alopecia Treatment

Restraints:
Probable Side Effects and Allergies Caused due to Alopecia Treatment

Opportunities:
Increasing R & D Investment For Hair Loss Treatment and Demand for Surgical Hair Transplant

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Alopecia Market
- Analysis about New Entrants in Alopecia Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Alopecia Study Sheds Light on
— The Alopecia Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Alopecia industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Alopecia industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Oral treatment
  • Topical treatment
  • Other treatment
By Application
  • Homecare Settings
  • Dermatology Clinics
  • Others (Salons)
By Treatment
  • Vitamins and Supplements
  • Shampoos and Conditioners
  • Others (Serums, Gels, and Oils)

By Gender
  • Male
  • Female

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Level of Genetic Disorders, Air and Water Pollution
      • 3.2.2. Rising Healthcare Expenditure
      • 3.2.3. Effective Treatment Option for Hair Treatment & its Awareness
      • 3.2.4. Demand for Alopecia Treatment in Developing Countries
    • 3.3. Market Challenges
      • 3.3.1. Cost Factor Associated with the Alopecia Treatment
    • 3.4. Market Trends
      • 3.4.1. Changing Lifestyle of People
      • 3.4.2. Growing Geriatric Population Undergoing Alopecia Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Alopecia, by Type, Application, Treatment, Gender and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Alopecia (Value)
      • 5.2.1. Global Alopecia by: Type (Value)
        • 5.2.1.1. Oral treatment
        • 5.2.1.2. Topical treatment
        • 5.2.1.3. Other treatment
      • 5.2.2. Global Alopecia by: Application (Value)
        • 5.2.2.1. Homecare Settings
        • 5.2.2.2. Dermatology Clinics
        • 5.2.2.3. Others (Salons)
      • 5.2.3. Global Alopecia by: Treatment (Value)
        • 5.2.3.1. Vitamins and Supplements
        • 5.2.3.2. Shampoos and Conditioners
        • 5.2.3.3. Others (Serums, Gels, and Oils)
      • 5.2.4. Global Alopecia by: Gender (Value)
        • 5.2.4.1. Male
        • 5.2.4.2. Female
      • 5.2.5. Global Alopecia Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Alopecia: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Lifes2good (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Kirkland Signature (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson Services (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Dr. Reddy's Laboratories (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cipla Inc.(India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Alpecin (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Vitabiotics Ltd. (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sun Pharmaceuticals Industries Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Phyto Ales Group (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Alopecia Sale, by Type, Application, Treatment, Gender and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Alopecia (Value)
      • 7.2.1. Global Alopecia by: Type (Value)
        • 7.2.1.1. Oral treatment
        • 7.2.1.2. Topical treatment
        • 7.2.1.3. Other treatment
      • 7.2.2. Global Alopecia by: Application (Value)
        • 7.2.2.1. Homecare Settings
        • 7.2.2.2. Dermatology Clinics
        • 7.2.2.3. Others (Salons)
      • 7.2.3. Global Alopecia by: Treatment (Value)
        • 7.2.3.1. Vitamins and Supplements
        • 7.2.3.2. Shampoos and Conditioners
        • 7.2.3.3. Others (Serums, Gels, and Oils)
      • 7.2.4. Global Alopecia by: Gender (Value)
        • 7.2.4.1. Male
        • 7.2.4.2. Female
      • 7.2.5. Global Alopecia Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Alopecia: by Type(USD Million)
  • Table 2. Alopecia Oral treatment , by Region USD Million (2017-2022)
  • Table 3. Alopecia Topical treatment , by Region USD Million (2017-2022)
  • Table 4. Alopecia Other treatment , by Region USD Million (2017-2022)
  • Table 5. Alopecia: by Application(USD Million)
  • Table 6. Alopecia Homecare Settings , by Region USD Million (2017-2022)
  • Table 7. Alopecia Dermatology Clinics , by Region USD Million (2017-2022)
  • Table 8. Alopecia Others (Salons) , by Region USD Million (2017-2022)
  • Table 9. Alopecia: by Treatment(USD Million)
  • Table 10. Alopecia Vitamins and Supplements , by Region USD Million (2017-2022)
  • Table 11. Alopecia Shampoos and Conditioners , by Region USD Million (2017-2022)
  • Table 12. Alopecia Others (Serums, Gels, and Oils) , by Region USD Million (2017-2022)
  • Table 13. Alopecia: by Gender(USD Million)
  • Table 14. Alopecia Male , by Region USD Million (2017-2022)
  • Table 15. Alopecia Female , by Region USD Million (2017-2022)
  • Table 16. South America Alopecia, by Country USD Million (2017-2022)
  • Table 17. South America Alopecia, by Type USD Million (2017-2022)
  • Table 18. South America Alopecia, by Application USD Million (2017-2022)
  • Table 19. South America Alopecia, by Treatment USD Million (2017-2022)
  • Table 20. South America Alopecia, by Gender USD Million (2017-2022)
  • Table 21. Brazil Alopecia, by Type USD Million (2017-2022)
  • Table 22. Brazil Alopecia, by Application USD Million (2017-2022)
  • Table 23. Brazil Alopecia, by Treatment USD Million (2017-2022)
  • Table 24. Brazil Alopecia, by Gender USD Million (2017-2022)
  • Table 25. Argentina Alopecia, by Type USD Million (2017-2022)
  • Table 26. Argentina Alopecia, by Application USD Million (2017-2022)
  • Table 27. Argentina Alopecia, by Treatment USD Million (2017-2022)
  • Table 28. Argentina Alopecia, by Gender USD Million (2017-2022)
  • Table 29. Rest of South America Alopecia, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Alopecia, by Application USD Million (2017-2022)
  • Table 31. Rest of South America Alopecia, by Treatment USD Million (2017-2022)
  • Table 32. Rest of South America Alopecia, by Gender USD Million (2017-2022)
  • Table 33. Asia Pacific Alopecia, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Alopecia, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Alopecia, by Application USD Million (2017-2022)
  • Table 36. Asia Pacific Alopecia, by Treatment USD Million (2017-2022)
  • Table 37. Asia Pacific Alopecia, by Gender USD Million (2017-2022)
  • Table 38. China Alopecia, by Type USD Million (2017-2022)
  • Table 39. China Alopecia, by Application USD Million (2017-2022)
  • Table 40. China Alopecia, by Treatment USD Million (2017-2022)
  • Table 41. China Alopecia, by Gender USD Million (2017-2022)
  • Table 42. Japan Alopecia, by Type USD Million (2017-2022)
  • Table 43. Japan Alopecia, by Application USD Million (2017-2022)
  • Table 44. Japan Alopecia, by Treatment USD Million (2017-2022)
  • Table 45. Japan Alopecia, by Gender USD Million (2017-2022)
  • Table 46. India Alopecia, by Type USD Million (2017-2022)
  • Table 47. India Alopecia, by Application USD Million (2017-2022)
  • Table 48. India Alopecia, by Treatment USD Million (2017-2022)
  • Table 49. India Alopecia, by Gender USD Million (2017-2022)
  • Table 50. South Korea Alopecia, by Type USD Million (2017-2022)
  • Table 51. South Korea Alopecia, by Application USD Million (2017-2022)
  • Table 52. South Korea Alopecia, by Treatment USD Million (2017-2022)
  • Table 53. South Korea Alopecia, by Gender USD Million (2017-2022)
  • Table 54. Taiwan Alopecia, by Type USD Million (2017-2022)
  • Table 55. Taiwan Alopecia, by Application USD Million (2017-2022)
  • Table 56. Taiwan Alopecia, by Treatment USD Million (2017-2022)
  • Table 57. Taiwan Alopecia, by Gender USD Million (2017-2022)
  • Table 58. Australia Alopecia, by Type USD Million (2017-2022)
  • Table 59. Australia Alopecia, by Application USD Million (2017-2022)
  • Table 60. Australia Alopecia, by Treatment USD Million (2017-2022)
  • Table 61. Australia Alopecia, by Gender USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Alopecia, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Alopecia, by Application USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Alopecia, by Treatment USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Alopecia, by Gender USD Million (2017-2022)
  • Table 66. Europe Alopecia, by Country USD Million (2017-2022)
  • Table 67. Europe Alopecia, by Type USD Million (2017-2022)
  • Table 68. Europe Alopecia, by Application USD Million (2017-2022)
  • Table 69. Europe Alopecia, by Treatment USD Million (2017-2022)
  • Table 70. Europe Alopecia, by Gender USD Million (2017-2022)
  • Table 71. Germany Alopecia, by Type USD Million (2017-2022)
  • Table 72. Germany Alopecia, by Application USD Million (2017-2022)
  • Table 73. Germany Alopecia, by Treatment USD Million (2017-2022)
  • Table 74. Germany Alopecia, by Gender USD Million (2017-2022)
  • Table 75. France Alopecia, by Type USD Million (2017-2022)
  • Table 76. France Alopecia, by Application USD Million (2017-2022)
  • Table 77. France Alopecia, by Treatment USD Million (2017-2022)
  • Table 78. France Alopecia, by Gender USD Million (2017-2022)
  • Table 79. Italy Alopecia, by Type USD Million (2017-2022)
  • Table 80. Italy Alopecia, by Application USD Million (2017-2022)
  • Table 81. Italy Alopecia, by Treatment USD Million (2017-2022)
  • Table 82. Italy Alopecia, by Gender USD Million (2017-2022)
  • Table 83. United Kingdom Alopecia, by Type USD Million (2017-2022)
  • Table 84. United Kingdom Alopecia, by Application USD Million (2017-2022)
  • Table 85. United Kingdom Alopecia, by Treatment USD Million (2017-2022)
  • Table 86. United Kingdom Alopecia, by Gender USD Million (2017-2022)
  • Table 87. Netherlands Alopecia, by Type USD Million (2017-2022)
  • Table 88. Netherlands Alopecia, by Application USD Million (2017-2022)
  • Table 89. Netherlands Alopecia, by Treatment USD Million (2017-2022)
  • Table 90. Netherlands Alopecia, by Gender USD Million (2017-2022)
  • Table 91. Rest of Europe Alopecia, by Type USD Million (2017-2022)
  • Table 92. Rest of Europe Alopecia, by Application USD Million (2017-2022)
  • Table 93. Rest of Europe Alopecia, by Treatment USD Million (2017-2022)
  • Table 94. Rest of Europe Alopecia, by Gender USD Million (2017-2022)
  • Table 95. MEA Alopecia, by Country USD Million (2017-2022)
  • Table 96. MEA Alopecia, by Type USD Million (2017-2022)
  • Table 97. MEA Alopecia, by Application USD Million (2017-2022)
  • Table 98. MEA Alopecia, by Treatment USD Million (2017-2022)
  • Table 99. MEA Alopecia, by Gender USD Million (2017-2022)
  • Table 100. Middle East Alopecia, by Type USD Million (2017-2022)
  • Table 101. Middle East Alopecia, by Application USD Million (2017-2022)
  • Table 102. Middle East Alopecia, by Treatment USD Million (2017-2022)
  • Table 103. Middle East Alopecia, by Gender USD Million (2017-2022)
  • Table 104. Africa Alopecia, by Type USD Million (2017-2022)
  • Table 105. Africa Alopecia, by Application USD Million (2017-2022)
  • Table 106. Africa Alopecia, by Treatment USD Million (2017-2022)
  • Table 107. Africa Alopecia, by Gender USD Million (2017-2022)
  • Table 108. North America Alopecia, by Country USD Million (2017-2022)
  • Table 109. North America Alopecia, by Type USD Million (2017-2022)
  • Table 110. North America Alopecia, by Application USD Million (2017-2022)
  • Table 111. North America Alopecia, by Treatment USD Million (2017-2022)
  • Table 112. North America Alopecia, by Gender USD Million (2017-2022)
  • Table 113. United States Alopecia, by Type USD Million (2017-2022)
  • Table 114. United States Alopecia, by Application USD Million (2017-2022)
  • Table 115. United States Alopecia, by Treatment USD Million (2017-2022)
  • Table 116. United States Alopecia, by Gender USD Million (2017-2022)
  • Table 117. Canada Alopecia, by Type USD Million (2017-2022)
  • Table 118. Canada Alopecia, by Application USD Million (2017-2022)
  • Table 119. Canada Alopecia, by Treatment USD Million (2017-2022)
  • Table 120. Canada Alopecia, by Gender USD Million (2017-2022)
  • Table 121. Mexico Alopecia, by Type USD Million (2017-2022)
  • Table 122. Mexico Alopecia, by Application USD Million (2017-2022)
  • Table 123. Mexico Alopecia, by Treatment USD Million (2017-2022)
  • Table 124. Mexico Alopecia, by Gender USD Million (2017-2022)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Alopecia: by Type(USD Million)
  • Table 135. Alopecia Oral treatment , by Region USD Million (2023-2028)
  • Table 136. Alopecia Topical treatment , by Region USD Million (2023-2028)
  • Table 137. Alopecia Other treatment , by Region USD Million (2023-2028)
  • Table 138. Alopecia: by Application(USD Million)
  • Table 139. Alopecia Homecare Settings , by Region USD Million (2023-2028)
  • Table 140. Alopecia Dermatology Clinics , by Region USD Million (2023-2028)
  • Table 141. Alopecia Others (Salons) , by Region USD Million (2023-2028)
  • Table 142. Alopecia: by Treatment(USD Million)
  • Table 143. Alopecia Vitamins and Supplements , by Region USD Million (2023-2028)
  • Table 144. Alopecia Shampoos and Conditioners , by Region USD Million (2023-2028)
  • Table 145. Alopecia Others (Serums, Gels, and Oils) , by Region USD Million (2023-2028)
  • Table 146. Alopecia: by Gender(USD Million)
  • Table 147. Alopecia Male , by Region USD Million (2023-2028)
  • Table 148. Alopecia Female , by Region USD Million (2023-2028)
  • Table 149. South America Alopecia, by Country USD Million (2023-2028)
  • Table 150. South America Alopecia, by Type USD Million (2023-2028)
  • Table 151. South America Alopecia, by Application USD Million (2023-2028)
  • Table 152. South America Alopecia, by Treatment USD Million (2023-2028)
  • Table 153. South America Alopecia, by Gender USD Million (2023-2028)
  • Table 154. Brazil Alopecia, by Type USD Million (2023-2028)
  • Table 155. Brazil Alopecia, by Application USD Million (2023-2028)
  • Table 156. Brazil Alopecia, by Treatment USD Million (2023-2028)
  • Table 157. Brazil Alopecia, by Gender USD Million (2023-2028)
  • Table 158. Argentina Alopecia, by Type USD Million (2023-2028)
  • Table 159. Argentina Alopecia, by Application USD Million (2023-2028)
  • Table 160. Argentina Alopecia, by Treatment USD Million (2023-2028)
  • Table 161. Argentina Alopecia, by Gender USD Million (2023-2028)
  • Table 162. Rest of South America Alopecia, by Type USD Million (2023-2028)
  • Table 163. Rest of South America Alopecia, by Application USD Million (2023-2028)
  • Table 164. Rest of South America Alopecia, by Treatment USD Million (2023-2028)
  • Table 165. Rest of South America Alopecia, by Gender USD Million (2023-2028)
  • Table 166. Asia Pacific Alopecia, by Country USD Million (2023-2028)
  • Table 167. Asia Pacific Alopecia, by Type USD Million (2023-2028)
  • Table 168. Asia Pacific Alopecia, by Application USD Million (2023-2028)
  • Table 169. Asia Pacific Alopecia, by Treatment USD Million (2023-2028)
  • Table 170. Asia Pacific Alopecia, by Gender USD Million (2023-2028)
  • Table 171. China Alopecia, by Type USD Million (2023-2028)
  • Table 172. China Alopecia, by Application USD Million (2023-2028)
  • Table 173. China Alopecia, by Treatment USD Million (2023-2028)
  • Table 174. China Alopecia, by Gender USD Million (2023-2028)
  • Table 175. Japan Alopecia, by Type USD Million (2023-2028)
  • Table 176. Japan Alopecia, by Application USD Million (2023-2028)
  • Table 177. Japan Alopecia, by Treatment USD Million (2023-2028)
  • Table 178. Japan Alopecia, by Gender USD Million (2023-2028)
  • Table 179. India Alopecia, by Type USD Million (2023-2028)
  • Table 180. India Alopecia, by Application USD Million (2023-2028)
  • Table 181. India Alopecia, by Treatment USD Million (2023-2028)
  • Table 182. India Alopecia, by Gender USD Million (2023-2028)
  • Table 183. South Korea Alopecia, by Type USD Million (2023-2028)
  • Table 184. South Korea Alopecia, by Application USD Million (2023-2028)
  • Table 185. South Korea Alopecia, by Treatment USD Million (2023-2028)
  • Table 186. South Korea Alopecia, by Gender USD Million (2023-2028)
  • Table 187. Taiwan Alopecia, by Type USD Million (2023-2028)
  • Table 188. Taiwan Alopecia, by Application USD Million (2023-2028)
  • Table 189. Taiwan Alopecia, by Treatment USD Million (2023-2028)
  • Table 190. Taiwan Alopecia, by Gender USD Million (2023-2028)
  • Table 191. Australia Alopecia, by Type USD Million (2023-2028)
  • Table 192. Australia Alopecia, by Application USD Million (2023-2028)
  • Table 193. Australia Alopecia, by Treatment USD Million (2023-2028)
  • Table 194. Australia Alopecia, by Gender USD Million (2023-2028)
  • Table 195. Rest of Asia-Pacific Alopecia, by Type USD Million (2023-2028)
  • Table 196. Rest of Asia-Pacific Alopecia, by Application USD Million (2023-2028)
  • Table 197. Rest of Asia-Pacific Alopecia, by Treatment USD Million (2023-2028)
  • Table 198. Rest of Asia-Pacific Alopecia, by Gender USD Million (2023-2028)
  • Table 199. Europe Alopecia, by Country USD Million (2023-2028)
  • Table 200. Europe Alopecia, by Type USD Million (2023-2028)
  • Table 201. Europe Alopecia, by Application USD Million (2023-2028)
  • Table 202. Europe Alopecia, by Treatment USD Million (2023-2028)
  • Table 203. Europe Alopecia, by Gender USD Million (2023-2028)
  • Table 204. Germany Alopecia, by Type USD Million (2023-2028)
  • Table 205. Germany Alopecia, by Application USD Million (2023-2028)
  • Table 206. Germany Alopecia, by Treatment USD Million (2023-2028)
  • Table 207. Germany Alopecia, by Gender USD Million (2023-2028)
  • Table 208. France Alopecia, by Type USD Million (2023-2028)
  • Table 209. France Alopecia, by Application USD Million (2023-2028)
  • Table 210. France Alopecia, by Treatment USD Million (2023-2028)
  • Table 211. France Alopecia, by Gender USD Million (2023-2028)
  • Table 212. Italy Alopecia, by Type USD Million (2023-2028)
  • Table 213. Italy Alopecia, by Application USD Million (2023-2028)
  • Table 214. Italy Alopecia, by Treatment USD Million (2023-2028)
  • Table 215. Italy Alopecia, by Gender USD Million (2023-2028)
  • Table 216. United Kingdom Alopecia, by Type USD Million (2023-2028)
  • Table 217. United Kingdom Alopecia, by Application USD Million (2023-2028)
  • Table 218. United Kingdom Alopecia, by Treatment USD Million (2023-2028)
  • Table 219. United Kingdom Alopecia, by Gender USD Million (2023-2028)
  • Table 220. Netherlands Alopecia, by Type USD Million (2023-2028)
  • Table 221. Netherlands Alopecia, by Application USD Million (2023-2028)
  • Table 222. Netherlands Alopecia, by Treatment USD Million (2023-2028)
  • Table 223. Netherlands Alopecia, by Gender USD Million (2023-2028)
  • Table 224. Rest of Europe Alopecia, by Type USD Million (2023-2028)
  • Table 225. Rest of Europe Alopecia, by Application USD Million (2023-2028)
  • Table 226. Rest of Europe Alopecia, by Treatment USD Million (2023-2028)
  • Table 227. Rest of Europe Alopecia, by Gender USD Million (2023-2028)
  • Table 228. MEA Alopecia, by Country USD Million (2023-2028)
  • Table 229. MEA Alopecia, by Type USD Million (2023-2028)
  • Table 230. MEA Alopecia, by Application USD Million (2023-2028)
  • Table 231. MEA Alopecia, by Treatment USD Million (2023-2028)
  • Table 232. MEA Alopecia, by Gender USD Million (2023-2028)
  • Table 233. Middle East Alopecia, by Type USD Million (2023-2028)
  • Table 234. Middle East Alopecia, by Application USD Million (2023-2028)
  • Table 235. Middle East Alopecia, by Treatment USD Million (2023-2028)
  • Table 236. Middle East Alopecia, by Gender USD Million (2023-2028)
  • Table 237. Africa Alopecia, by Type USD Million (2023-2028)
  • Table 238. Africa Alopecia, by Application USD Million (2023-2028)
  • Table 239. Africa Alopecia, by Treatment USD Million (2023-2028)
  • Table 240. Africa Alopecia, by Gender USD Million (2023-2028)
  • Table 241. North America Alopecia, by Country USD Million (2023-2028)
  • Table 242. North America Alopecia, by Type USD Million (2023-2028)
  • Table 243. North America Alopecia, by Application USD Million (2023-2028)
  • Table 244. North America Alopecia, by Treatment USD Million (2023-2028)
  • Table 245. North America Alopecia, by Gender USD Million (2023-2028)
  • Table 246. United States Alopecia, by Type USD Million (2023-2028)
  • Table 247. United States Alopecia, by Application USD Million (2023-2028)
  • Table 248. United States Alopecia, by Treatment USD Million (2023-2028)
  • Table 249. United States Alopecia, by Gender USD Million (2023-2028)
  • Table 250. Canada Alopecia, by Type USD Million (2023-2028)
  • Table 251. Canada Alopecia, by Application USD Million (2023-2028)
  • Table 252. Canada Alopecia, by Treatment USD Million (2023-2028)
  • Table 253. Canada Alopecia, by Gender USD Million (2023-2028)
  • Table 254. Mexico Alopecia, by Type USD Million (2023-2028)
  • Table 255. Mexico Alopecia, by Application USD Million (2023-2028)
  • Table 256. Mexico Alopecia, by Treatment USD Million (2023-2028)
  • Table 257. Mexico Alopecia, by Gender USD Million (2023-2028)
  • Table 258. Research Programs/Design for This Report
  • Table 259. Key Data Information from Secondary Sources
  • Table 260. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Alopecia: by Type USD Million (2017-2022)
  • Figure 5. Global Alopecia: by Application USD Million (2017-2022)
  • Figure 6. Global Alopecia: by Treatment USD Million (2017-2022)
  • Figure 7. Global Alopecia: by Gender USD Million (2017-2022)
  • Figure 8. South America Alopecia Share (%), by Country
  • Figure 9. Asia Pacific Alopecia Share (%), by Country
  • Figure 10. Europe Alopecia Share (%), by Country
  • Figure 11. MEA Alopecia Share (%), by Country
  • Figure 12. North America Alopecia Share (%), by Country
  • Figure 13. Global Alopecia share by Players 2022 (%)
  • Figure 14. Global Alopecia share by Players (Top 3) 2022(%)
  • Figure 15. Global Alopecia share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Lifes2good (Ireland) Revenue, Net Income and Gross profit
  • Figure 18. Lifes2good (Ireland) Revenue: by Geography 2022
  • Figure 19. Kirkland Signature (United States) Revenue, Net Income and Gross profit
  • Figure 20. Kirkland Signature (United States) Revenue: by Geography 2022
  • Figure 21. Johnson & Johnson Services (United States) Revenue, Net Income and Gross profit
  • Figure 22. Johnson & Johnson Services (United States) Revenue: by Geography 2022
  • Figure 23. Dr. Reddy's Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 24. Dr. Reddy's Laboratories (India) Revenue: by Geography 2022
  • Figure 25. Cipla Inc.(India) Revenue, Net Income and Gross profit
  • Figure 26. Cipla Inc.(India) Revenue: by Geography 2022
  • Figure 27. Alpecin (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Alpecin (Germany) Revenue: by Geography 2022
  • Figure 29. Vitabiotics Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Vitabiotics Ltd. (United Kingdom) Revenue: by Geography 2022
  • Figure 31. Sun Pharmaceuticals Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 32. Sun Pharmaceuticals Industries Ltd. (India) Revenue: by Geography 2022
  • Figure 33. Phyto Ales Group (France) Revenue, Net Income and Gross profit
  • Figure 34. Phyto Ales Group (France) Revenue: by Geography 2022
  • Figure 35. Global Alopecia: by Type USD Million (2023-2028)
  • Figure 36. Global Alopecia: by Application USD Million (2023-2028)
  • Figure 37. Global Alopecia: by Treatment USD Million (2023-2028)
  • Figure 38. Global Alopecia: by Gender USD Million (2023-2028)
  • Figure 39. South America Alopecia Share (%), by Country
  • Figure 40. Asia Pacific Alopecia Share (%), by Country
  • Figure 41. Europe Alopecia Share (%), by Country
  • Figure 42. MEA Alopecia Share (%), by Country
  • Figure 43. North America Alopecia Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Lifes2good (Ireland)
  • Kirkland Signature (United States)
  • Johnson & Johnson Services (United States)
  • Dr. Reddy's Laboratories (India)
  • Cipla Inc.(India)
  • Alpecin (Germany)
  • Vitabiotics Ltd. (United Kingdom)
  • Sun Pharmaceuticals Industries Ltd. (India)
  • Phyto Ales Group (France)
Select User Access Type

Key Highlights of Report


May 2023 221 Pages 89 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Alopecia Market Quantitative research analysis
Global Alopecia Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Alopecia market are Lifes2good (Ireland), Kirkland Signature (United States), Johnson & Johnson Services (United States), Dr. Reddy's Laboratories (India), Cipla Inc.(India), Alpecin (Germany), Vitabiotics Ltd. (United Kingdom), Sun Pharmaceuticals Industries Ltd. (India) and Phyto Ales Group (France), to name a few.
North America is dominating the Alopecia Market.
"Cost Factor Associated with the Alopecia Treatment" is seen as one of the major challenges by many Industry Players of Alopecia Market
The Alopecia market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Alopecia market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Alopecia Market Report?

Have a Query? Click Here

Other Related Reports

Endometriosis Treatment Comprehensive Study by Type (Gonadotropins releasing hormone agonists, Progestin, Non-steroidal anti-inflammatory drugs, Oral contraceptive pills), Application (Hospital pharm...
$ 3450
Pet Cancer Therapeutics Comprehensive Study by Type (Chemotherapy Drugs, Vaccines), Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary, Squamous Cell Cancer, Others), Treatment (Chemotherapy,...
$ 3450
Influenza Diagnostics Comprehensive Study by Type (Rapid Influenza Diagnostic Tests (RIDT), Direct Fluorescent Antibody (DFA) Tests, Molecular Diagnostic Tests, Traditional Diagnostic Tests, Viral Cu...
$ 3450
Prosthetic Heart Valves Comprehensive Study by Type (Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve), End User (Hospitals, Ambulatory Surgical Centers, Others) Players and Regi...
$ 3500
Cystoscope Comprehensive Study by Type (Rigid Cystoscope, Flexible Cystoscope), Application (Urology, Gynaecology), End User (Hospitals & Clinics, Ambulatory Surgical Centers) Players and Region - Gl...
$ 3500
Diuretics Comprehensive Study by Type (Thiazide diuretics, Loop diuretics, Potassium-sparing diuretics), Application (Hypertension, Edema, Hypercalciuria, Diabetes, Insipidus, Others), Distribution C...
$ 3750